The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca Plc (NYSE:AZN) and Ranbaxy Laboratories Limited (NYSE:RBXLY) on a long-lasting class action lawsuit involving an illegal agreement between the two companies related to ... 4 Traders, 1 week ago
AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins Over Illegal Deal Case - InsiderMonkey.com, 1 week ago
By Brendan Pierson (Reuters) - A U.S. appeals court upheld AstraZeneca Plc and Ranbaxy Laboratories' victory in a lawsuit accusing them of reaching an illegal deal to delay the launch of a generic version of AstraZeneca's heartburn drug Nexium. ...Yahoo! UK and Ireland, 1 week ago ASTRAZENECA : U.S. court upholds AstraZeneca, Ranbaxy win in Nexium antitrust trial 4 Traders, 1 week ago
Finasteride Market: Industry Analysis Report, Regional Outlook, Application Development Potential & Forecast, 2016 2024.
"Finasteride market share comprises of Merck Sharp & Dohme, Sun Pharmaceuticals, Ranbaxy Laboratories, Dr. Reddys Laboratories and Intas Pharmaceuticals, Teva Pharmaceuticals, Actavis, Hetero Labs, Yabao Pharmaceuticals, Cipla, Yangtze River Pharma, ...Digital Journal, 1 week ago
Compliance Wrap: Heparin quality concerns re-emerge in China, more trouble at Sun Pharma & Wockhardt
View: 426 PharmaCompass looks at recent compliance concerns highlighted by the US FDA at drug manufacturers like India's Sun Pharmaceuticals, Srikem Labs, Wockhardt's UK subsidiary and China's Dongying Tiandong. This is not the first time most ...PharmaCompass, 4 days ago
Hello, everyone, and how are you today? We are just fine, thank you, despite a spot of rain descending on the Pharmalot campus. Our spirits, in fact, remain as sunny as ever. After all, as the Morning Mayor once said: Every brand new day should be ...StatNews.com, 6 days ago Pharmalot, Pharmalittle: FDA approves Sanofi and Novo diabetes drugs StatNews.com, 1 week ago Pharmalot, Pharmalittle: New bill would create review board for drug prices StatNews.com, 1 month ago
TechNavio - Infiniti Research Ltd. About Alopecia Drugs Alopecia is a loss of hair and can occur at any age across the genders. The exact cause of this disorder is unknown, but many factors are assumed to be responsible for developing alopecia.MarketResearch.com, 6 days ago Global Alopecia Drugs Market Forecast to 2020 with Competitive Landscape Analysis and Key Companies Profile Before It's News, 1 week ago
RHC Holding said to be in talks with Nomura Capital and Edelweiss Financial Services to run the loan syndication process Mumbai: RHC Holding Pvt. Ltd (RHPL), the holding company for the Religare and Fortis brands, among others, is in talks to ...Livemint.com, 1 week ago India: Religare holding firm in talks to refinance $300m debt DealStreetAsia, 1 week ago
NEW DELHI: Shares of Sun Pharma rose up to 2 per cent in Friday's trade as reports suggested that the USFDA recorded seven observations as part of its recent inspection of the company's manufacturing site at Mohali. The stock rose 1.96 per cent to ...Economic Times, 1 week ago Sun Pharma's Mohali unit violated manufacturing norms, finds US FDA Livemint.com, 1 week ago
Image: Vikas Khot In 2000-01, the HIV/Aids threat had intensified across sub-Saharan Africa, affecting millions. To compound the problem, the medicines that could help treat the condition were prohibitively priced, making them unaffordable for the ...Forbes India, 1 week ago
Sun Pharmaceutical closed Rs 712.15 a share on Friday on Bombay Stock Exchange (BSE), a 4% gain from its previous day close as rupee depreciation helped export led companies to gain. But it has hardly cheered the investors who saw a dream run for ...Smart Investor, 1 week ago
on your WebpageAdd Widget >Get your members hooked!